DiviDrip · PHAT

PHAT — Phathom Pharmaceuticals, Inc.

PHAT is Phathom Pharmaceuticals, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $9.50. Market cap: $769M. Capital Quality Rank: 38/100 — Stagnant mediocrity.

Stock snapshot

Price$9.50
Market cap$769M
SectorHealthcare
ExchangeNMS
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)38 / 100 · Stagnant mediocrity
Shareholder buyback yield-13.36%
Altman Z-score zoneDistress

About PHAT

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Listed2019Employees371HQFlorham Park, NJSectorHealthcareWebsitephathompharma.com

Related non-dividend companies

Other non-dividend stocks investors research alongside PHAT. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is PHAT's current stock price?

PHAT (Phathom Pharmaceuticals, Inc.) is currently trading at $9.50.

Does PHAT pay a dividend?

PHAT (Phathom Pharmaceuticals, Inc.) does not currently pay a regular dividend.

What is PHAT's Capital Quality Rank?

PHAT has a Capital Quality Rank of 38/100 — Stagnant mediocrity. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track PHAT in DiviDrip

Add PHAT to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-06. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow